Limits on Antibiotics for Lyme Disease: Why Doctors Are in Limbo
As many as one-third of patients with Lyme disease are ill on long-term follow-up. A population-based, retrospective cohort study in Massachusetts found that 34% of patients suffered from arthritis or recurrent arthralgias, neurocognitive impairment, and neuropathy or myelopathy an average of six years after treatment for Lyme disease. [1] These limits on antibiotics for Lyme […]
Limits on Antibiotics for Lyme Disease: Why Doctors Are in Limbo Read More »










